_id

690f386accc777a4e85d1860

Ticker

BRNS

Name

Barinthus Biotherapeutics plc

Exchange

NASDAQ

Address

Zeus Building, Didcot, United Kingdom, OX11 0DF

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.barinthusbio.com

Description

Barinthus Biotherapeutics plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapeutic drug candidates for treating auto-immune and inflammatory diseases. Its lead candidate is VTP-1000, which is in Phase 1 clinical trial to restore immune non-responsiveness to gluten in patients with celiac disease. The company is also developing VTP-300, an immunotherapeutic targeting chronic hepatitis B virus infection; VTP-200, a potential non-invasive treatment for persistent high-risk human papillomavirus; VTP-850, an immunotherapeutic candidate for prostate cancer; VTP-600, an immunotherapeutic candidate targeting MAGE-A3 and NY-ESO1 antigens; VTP-500, a prophylactic vaccine candidate to prevent middle east respiratory syndrome; VTP-400, a prophylactic vaccine candidate for shingles; and Vaxzevria, a prophylactic vaccine for the prevention of COVID-19 infection. The company was formerly known as Vaccitech plc and changed its name to Barinthus Biotherapeutics plc in November 2023. Barinthus Biotherapeutics plc was founded in 2016 and is headquartered in Didcot, the United Kingdom.

Last Close

0.7204

Volume

36202

Current Price

0.6793

Change

-5.705163797890064

Last Updated

2025-11-28T13:08:24.304Z

Image

data:image/webp;base64,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

Ipo Date

2021-04-30T00:00:00.000Z

Market Cap

31606776

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.6714

Sentiment Sources

5

Rating

4.6667

Target Price

5.5

Strong Buy

2

Buy

1

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

-

Gross Profit

-

Operating Expenses

15066000

Operating Income

-15066000

Interest Expense

13000

Pretax Income

-14642000

Net Income

-14566000

Eps

-0.3582292056012823

Dividends Per Share

-

Shares Outstanding

40830353

Income Tax Expense

-71000

EBITDA

-13428000

Operating Margin

-

Total Other Income Expense Net

424000

Cash

74272000

Short Term Investments

-

Receivables

-

Inventories

-

Total Current Assets

86781000

Property Plant Equipment

6582000

Total Assets

109201000

Payables

698000

Short Term Debt

2017000

Long Term Debt

-

Total Liabilities

24640000

Equity

84465000

Depreciation

901000

Change In Working Capital

-1462000

Cash From Operations

-10726000

Capital Expenditures

0

Cash From Investing

451000

Cash From Financing

-9.51

Net Change In Cash

-12110000

PE

-

PB

0.3270123418859883

ROE

-17.245012727165097

ROA

-13.338705689508338

FCF

-10726000

Fcf Percent

-

Piotroski FScore

1

Health Score

42

Deep Value Investing Score

6.5

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

3.8

Garp Investing Score

2

Growth Investing Score

0.5

Momentum Investing Score

3

Net Net Investing Score

7

Quality Investing Score

2.5

Value Investing Score

5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

-

Quarters > 0 > income Statement > operating Expenses

15066000

Quarters > 0 > income Statement > operating Income

-15066000

Quarters > 0 > income Statement > interest Expense

13000

Quarters > 0 > income Statement > pretax Income

-14642000

Quarters > 0 > income Statement > net Income

-14566000

Quarters > 0 > income Statement > eps

-0.3582292056012823

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

40661118

Quarters > 0 > income Statement > income Tax Expense

-71000

Quarters > 0 > income Statement > EBITDA

-13428000

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

424000

Quarters > 0 > balance Sheet > cash

74272000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

86781000

Quarters > 0 > balance Sheet > property Plant Equipment

6582000

Quarters > 0 > balance Sheet > total Assets

109201000

Quarters > 0 > balance Sheet > payables

698000

Quarters > 0 > balance Sheet > short Term Debt

2017000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

24640000

Quarters > 0 > balance Sheet > equity

84465000

Quarters > 0 > cash Flow > net Income

-14571000

Quarters > 0 > cash Flow > depreciation

901000

Quarters > 0 > cash Flow > change In Working Capital

-1462000

Quarters > 0 > cash Flow > cash From Operations

-10726000

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

451000

Quarters > 0 > cash Flow > cash From Financing

-9.51

Quarters > 0 > cash Flow > net Change In Cash

-12110000

Quarters > 0 > ratios > PE

-0.3582292056012823

Quarters > 0 > ratios > PB

0.3270123418859883

Quarters > 0 > ratios > ROE

-17.245012727165097

Quarters > 0 > ratios > ROA

-13.338705689508338

Quarters > 0 > ratios > FCF

-10726000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

42

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

2024681

Quarters > 1 > income Statement > gross Profit

-2024681

Quarters > 1 > income Statement > operating Expenses

23324000

Quarters > 1 > income Statement > operating Income

-23324000

Quarters > 1 > income Statement > interest Expense

12000

Quarters > 1 > income Statement > pretax Income

-21151000

Quarters > 1 > income Statement > net Income

-21124000

Quarters > 1 > income Statement > eps

-0.5236032819247483

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

40343521

Quarters > 1 > income Statement > income Tax Expense

-25000

Quarters > 1 > income Statement > EBITDA

-19138000

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

2173000

Quarters > 1 > balance Sheet > cash

86259000

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

5013000

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

100414000

Quarters > 1 > balance Sheet > property Plant Equipment

7837000

Quarters > 1 > balance Sheet > total Assets

129561000

Quarters > 1 > balance Sheet > payables

1800000

Quarters > 1 > balance Sheet > short Term Debt

2036000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

27080000

Quarters > 1 > balance Sheet > equity

102377000

Quarters > 1 > cash Flow > net Income

-21126000

Quarters > 1 > cash Flow > depreciation

2001000

Quarters > 1 > cash Flow > change In Working Capital

-2198000

Quarters > 1 > cash Flow > cash From Operations

-18109000

Quarters > 1 > cash Flow > capital Expenditures

32000

Quarters > 1 > cash Flow > cash From Investing

-32000

Quarters > 1 > cash Flow > cash From Financing

9.51

Quarters > 1 > cash Flow > net Change In Cash

-12795000

Quarters > 1 > ratios > PE

-0.5236032819247483

Quarters > 1 > ratios > PB

0.2676905341561093

Quarters > 1 > ratios > ROE

-20.633540736688904

Quarters > 1 > ratios > ROA

-16.304289099343166

Quarters > 1 > ratios > FCF

-18141000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

42

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

2041809

Quarters > 2 > income Statement > gross Profit

-2041809

Quarters > 2 > income Statement > operating Expenses

20600000

Quarters > 2 > income Statement > operating Income

-20600000

Quarters > 2 > income Statement > interest Expense

13000

Quarters > 2 > income Statement > pretax Income

-19680000

Quarters > 2 > income Statement > net Income

-19648000

Quarters > 2 > income Statement > eps

-0.4879645995193469

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

40265216

Quarters > 2 > income Statement > income Tax Expense

-22000

Quarters > 2 > income Statement > EBITDA

-17633000

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

920000

Quarters > 2 > balance Sheet > cash

99118000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

3857000

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

109882000

Quarters > 2 > balance Sheet > property Plant Equipment

10056000

Quarters > 2 > balance Sheet > total Assets

141996000

Quarters > 2 > balance Sheet > payables

1357000

Quarters > 2 > balance Sheet > short Term Debt

1960000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

26403000

Quarters > 2 > balance Sheet > equity

115494000

Quarters > 2 > cash Flow > net Income

-19658000

Quarters > 2 > cash Flow > depreciation

2034000

Quarters > 2 > cash Flow > change In Working Capital

-137000

Quarters > 2 > cash Flow > cash From Operations

-14902000

Quarters > 2 > cash Flow > capital Expenditures

5000

Quarters > 2 > cash Flow > cash From Investing

-5000

Quarters > 2 > cash Flow > cash From Financing

2000

Quarters > 2 > cash Flow > net Change In Cash

-11821000

Quarters > 2 > ratios > PE

-0.4879645995193469

Quarters > 2 > ratios > PB

0.23682755146414536

Quarters > 2 > ratios > ROE

-17.012139158744176

Quarters > 2 > ratios > ROA

-13.83700949322516

Quarters > 2 > ratios > FCF

-14907000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

42

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

-9173000

Quarters > 3 > income Statement > cost Of Revenue

2897827

Quarters > 3 > income Statement > gross Profit

-12071173

Quarters > 3 > income Statement > operating Expenses

23390000

Quarters > 3 > income Statement > operating Income

-23390000

Quarters > 3 > income Statement > interest Expense

12000

Quarters > 3 > income Statement > pretax Income

-20588000

Quarters > 3 > income Statement > net Income

-20540000

Quarters > 3 > income Statement > eps

-0.5220087425027956

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

39348000

Quarters > 3 > income Statement > income Tax Expense

3000

Quarters > 3 > income Statement > EBITDA

-19148000

Quarters > 3 > income Statement > operating Margin

254.98746320723865

Quarters > 3 > income Statement > total Other Income Expense Net

2802000

Quarters > 3 > balance Sheet > cash

110662000

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

12998000

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

125742000

Quarters > 3 > balance Sheet > property Plant Equipment

11757000

Quarters > 3 > balance Sheet > total Assets

160327000

Quarters > 3 > balance Sheet > payables

2474000

Quarters > 3 > balance Sheet > short Term Debt

1920000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

30192000

Quarters > 3 > balance Sheet > equity

130029000

Quarters > 3 > cash Flow > net Income

-20591000

Quarters > 3 > cash Flow > depreciation

1428000

Quarters > 3 > cash Flow > change In Working Capital

15152000

Quarters > 3 > cash Flow > cash From Operations

13086000

Quarters > 3 > cash Flow > capital Expenditures

278000

Quarters > 3 > cash Flow > cash From Investing

-278000

Quarters > 3 > cash Flow > cash From Financing

837000

Quarters > 3 > cash Flow > net Change In Cash

6298000

Quarters > 3 > ratios > PE

-0.5220087425027956

Quarters > 3 > ratios > PB

0.2055625775788478

Quarters > 3 > ratios > ROE

-15.796476170700382

Quarters > 3 > ratios > ROA

-12.811316871144598

Quarters > 3 > ratios > FCF

12808000

Quarters > 3 > ratios > Piotroski FScore

2

Quarters > 3 > ratios > fcf Percent

-1.3962716668483592

Quarters > 3 > health Score

35

Valuation > metrics > PE

-0.3582292056012823

Valuation > metrics > PB

0.3270123418859883

Valuation > final Score

70

Valuation > verdict

67.3% Undervalued

Profitability > metrics > ROE

-17.245012727165097

Profitability > metrics > ROA

-16.784780078588632

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.29171846326880957

Risk > metrics > Interest Coverage

-1158.923076923077

Risk > final Score

-4576

Risk > verdict

High

Liquidity > metrics > Current Ratio

31.96353591160221

Liquidity > metrics > Quick Ratio

31.96353591160221

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

70

Prev Valuations > 1

70

Prev Valuations > 2

70

Prev Profitabilities > 0

15

Prev Profitabilities > 1

15

Prev Profitabilities > 2

30

Prev Risks > 0

-7715

Prev Risks > 1

-6278

Prev Risks > 2

-7737

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:17:53.341Z